Tricyclic-Carbocyclic RORγt Inverse Agonists—Discovery of BMS-986313
- 16 February 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 64 (5), 2714-2724
- https://doi.org/10.1021/acs.jmedchem.0c01992
Abstract
SAR efforts directed at identifying RORγt inverse agonists structurally different from our clinical compound 1 (BMS-986251) led to tricyclic-carbocyclic analogues represented by 3–7 and culminated in the identification of 3d (BMS-986313), with structural differences distinct from 1. The X-ray co-crystal structure of 3d with the ligand binding domain of RORγt revealed several key interactions, which are different from 1. The in vitro and in vivo PK profiles of 3d are described. In addition, we demonstrate robust efficacy of 3d in two preclinical models of psoriasis—the IMQ-induced skin lesion model and the IL-23-induced acanthosis model. The efficacy seen with 3d in these models is comparable to the results observed with 1.Keywords
This publication has 28 references indexed in Scilit:
- Small molecule inhibitors of RORγt: Targeting Th17 cells and other applicationsEuropean Journal of Immunology, 2012
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for PsoriasisThe New England Journal of Medicine, 2012
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligandNature, 2011
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activityNature, 2011
- IL-17 and Th17 CellsAnnual Review of Immunology, 2009
- RORγ-Expressing Th17 Cells Induce Murine Chronic Intestinal Inflammation via Redundant Effects of IL-17A and IL-17FGastroenterology, 2009
- The genetics and immunopathogenesis of inflammatory bowel diseaseNature Reviews Immunology, 2008
- A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease GeneScience, 2006
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cellsNature Immunology, 2003